In addition, infiltrative invasion of glioma stem cells expressing EphA2 in vivo, which is completely independent of ephrin-A1, A3 and A4 ligands, was disrupted by S897A mutation43. The gene discussed is EPHA2; the disease is central nervous system cancer.